NCT05003999

Brief Summary

This study investigates the burden of intermittent catheterization in adult individuals with neurogenic lower urinary tract dysfunction (NLUTD) following spinal cord injury (SCI). Individuals will be recruited to compare two types of catheters. Each participant will use a non-hydrophilic catheter at one time point and a hydrophilic catheter at a different time point to perform intermittent catheterization. The order that participants use either a non-hydrophilic or a hydrophilic catheter will be determined randomly. The purpose of the study is to provide evidence for time spent on bladder management (performing intermittent catheterization) as well as consumer satisfaction on using both catheters.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Dec 2018

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2018

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 10, 2019

Completed
18 days until next milestone

Study Completion

Last participant's last visit for all outcomes

June 28, 2019

Completed
2 years until next milestone

First Submitted

Initial submission to the registry

June 22, 2021

Completed
2 months until next milestone

First Posted

Study publicly available on registry

August 13, 2021

Completed
Last Updated

August 13, 2021

Status Verified

August 1, 2021

Enrollment Period

6 months

First QC Date

June 22, 2021

Last Update Submit

August 4, 2021

Conditions

Keywords

Spinal Cord InjuryIntermittent CatheterizationHydrophilic CatheterNon-Hydrophilic CatheterQuality of LifeTimePreparationSatisfaction

Outcome Measures

Primary Outcomes (2)

  • Differences in time needed to perform intermittent catheterization between two types of catheters

    A measure of time (seconds) taken to perform intermittent catheterization using a 13 step pre-determined intermittent catheterization protocol where the first catheter will be different from the later catheter (i.e. hydrophilic vs. non-hydrophilic catheter).

    Through study completion, an average of two weeks

  • Difference in convenience to perform intermittent catheterization between two types of catheters

    To assess the difference in convenience (ease of handling) for two catheters, i.e. using a hydrophilic vs. a non-hydrophilic catheter, as determined by using a survey.

    Through study completion, an average of two weeks

Study Arms (2)

Intermittent catheterization starting with a hydrophilic catheter (HPC)

EXPERIMENTAL

The investigators measure the time taken to perform intermittent catheterization using a 13 step pre-determined intermittent catheterization protocol using a hydrophilic catheter i.e. SpeediCath ® (Coloplast A/S, Humlebæk, Denmark)

Device: HPC - SpeediCath ®

Intermittent catheterization starting with a non-hydrophilic catheter (non-HPC)

ACTIVE COMPARATOR

The investigators measure the time taken to perform intermittent catheterization using a 13 step pre-determined intermittent catheterization protocol using a non-hydrophilic catheter i.e. Self-Cath ® (Coloplast A/S, Humlebæk, Denmark); Lubrication jelly (MUKO ®, 3.5g package, Cardinal Health Canada Inc, Toronto, ON, Canada) was provided

Device: Non-HPC - Self-Cath ®

Interventions

The investigators measure the time taken to perform intermittent catheterization using a 13 step pre-determined intermittent catheterization protocol using a hydrophilic catheter

Also known as: Intermittent catheterization using a hydrophilic catheter (HPC)
Intermittent catheterization starting with a hydrophilic catheter (HPC)

The investigators measure the time taken to perform intermittent catheterization using a 13 step pre-determined intermittent catheterization protocol using a non-hydrophilic catheter; Lubrication jelly (MUKO ®, 3.5g package, Cardinal Health Canada Inc, Toronto, ON, Canada) was provided

Also known as: Intermittent catheterization using a non-hydrophilic catheter (non-HPC)
Intermittent catheterization starting with a non-hydrophilic catheter (non-HPC)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Female or male
  • years of age or older
  • Presenting with a chronic SCI (i.e. greater than one year post-injury) at any level and with any severity (i.e. American Spinal Injury Association scale grade A to E )
  • Hand function sufficient to perform intermittent catheterization for management of urinary bladder drainage
  • Willing and able to comply with all clinic visits and study-related procedures
  • Must provide informed consent and be able to understand and complete study-related instructions (must be able to understand and speak English)
  • Women must not be pregnant
  • Must not have any urinary diversion procedure, such as bladder augmentation, cystectomy, neo bladder, pouch reservoir, ileal conduit, Mitrofanoff appendicovesicostomy or similar

You may not qualify if:

  • Presence of severe acute medical issue that in the investigator's judgement would adversely affect the individual's participation in the study
  • Individuals who do not perform intermittent catheterization
  • Individuals who are members of the investigational team and immediate family

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of British Columbia

Vancouver, British Columbia, V5Z 1M9, Canada

Location

Related Links

MeSH Terms

Conditions

Spinal Cord InjuriesPersonal Satisfaction

Condition Hierarchy (Ancestors)

Spinal Cord DiseasesCentral Nervous System DiseasesNervous System DiseasesTrauma, Nervous SystemWounds and InjuriesBehavior

Study Officials

  • Andrei Krassioukov, MD, PhD, FRCPC

    University of British Columbia

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
CROSSOVER
Model Details: Two-by-two cross-over assignment
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

June 22, 2021

First Posted

August 13, 2021

Study Start

December 1, 2018

Primary Completion

June 10, 2019

Study Completion

June 28, 2019

Last Updated

August 13, 2021

Record last verified: 2021-08

Data Sharing

IPD Sharing
Will not share

Locations